Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial-Reference-Cited by-同舟云学术

Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial

Published:2020-05 Issue: Volume:130 Page:12-19
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zheng Yanan,Yang Xiao,Yan Chao,Feng Runhua,Sah Birendra Kumar,Yang Zhongyin,Zhu Zhenglun,Liu Wentao,Xu Wei,Ni Zhentian,Beeharry Maneesh Kumarsing,Hua Zichen,Yan Min,Zhu Zhenggang,Li Chen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer;Degiuli;Br J Canc,2004

3. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501;Sano;J Clin Oncol,2004

4. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study);Koizumi;Ann Oncol,2010

5. A randomized phase II trial of S-1-oxaliplatin versus capecitabine–oxaliplatin in advanced gastric cancer;Kim;Eur J Canc,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study;Cancer Immunology, Immunotherapy;2024-08-06

2. Recent efficacy and safety analysis of neoadjuvant therapy with Tislelizumab combined with Apatinib and chemotherapy in Borrmann type IV, large Borrmann type III, and Bulky N locally advanced gastric cancer(3-B).;2024-07-01

3. Prognostic significance of a pathological response in metastatic lymph nodes of patients with gastric cancer who underwent neoadjuvant chemotherapy followed by surgery;Surgery Today;2024-04-08

4. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study;International Journal of Surgery;2024-02-05

5. Fruquintinib plus oxaliplatin combined with S-1 (SOX) as neoadjuvant therapy for locally advanced gastric cancer (GC) or gastro-oesophageal junction adenocarcinoma (GEJ): a multicentre, phase II, single-arm, open-label clinical trial (FRUTINEOGA) protocol;BMJ Open;2024-02